Description
Mycoplasma infections—especially Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS)—are major causes of chronic respiratory disease (CRD) in poultry, leading to:
- Respiratory distress
- Reduced egg production
- Poor feed conversion
- Increased susceptibility to secondary infections
This inactivated MG + MS combined vaccine provides dual protection against both pathogens in a single injection, making it highly suitable for modern poultry production systems.
Key benefits include:
- Reduced respiratory disease incidence
- Improved laying performance and flock uniformity
- Lower antibiotic dependency
- Enhanced overall flock health
Ideal for:
- Layer farms
- Breeder farms
- Integrated poultry operations
Composition
- Inactivated Mycoplasma gallisepticum (CR strain) ≥ 3.0 × 108.5 CCU/mL
- Inactivated Mycoplasma synoviae (HY strain) ≥ 3.0 × 108.5 CCU/mL
Physical Characteristics
- Milky white emulsion
Indications
For prevention of:
- Chronic respiratory disease (CRD)
- Air sacculitis
- Synovitis caused by Mycoplasma synoviae
Immunity
- Duration of immunity: Up to 6 months
Dosage & Administration
Route:
- Subcutaneous injection (neck or back)
- Intramuscular injection (thigh)
Dosage
- Chickens <40 days: 0.25 mL/bird
- Chickens >40 days: 0.5 mL/bird
- Laying hens:
- Additional 0.5 mL before egg production
Recommended Immunization Strategy
- Broilers: Early-stage protection to reduce CRD impact
- Layers/Breeders:
- Primary vaccination during growing phase
- Booster before laying period
Safety & Adverse Reactions
- Generally safe
- No significant adverse reactions reported
Precautions
- Bring vaccine to room temperature and shake well before use
- Injection site: middle to lower neck (avoid head area)
- Disinfect injection site before use
- Follow aseptic procedures
- Dispose of used materials properly
- Do not use within 28 days before slaughter
Packaging & Specification
- 500 mL/bottle
- 20 bottles/carton
Storage & Shelf Life
- Store at 2–8°C
- Shelf life: 24 months
